Search

Displaying results 6681 - 6690 of 6949 in total
  1. Drug

    Robalzotan

    go.drugbank.com/drugs/DB06538
    Experimental

    Categories: Serotonin Receptor Antagonists, Serotonin 5-HT1 Receptor Antagonists
  2. Drug

    Gavilimomab

    go.drugbank.com/drugs/DB06545
    Investigational

  3. Drug

    Fispemifene

    go.drugbank.com/drugs/DB06640
    Investigational

  4. Drug

    Priralfinamide

    go.drugbank.com/drugs/DB06649
    Investigational

  5. Drug

    Almorexant

    go.drugbank.com/drugs/DB06673
    Investigational

  6. Drug

    Amediplase

    go.drugbank.com/drugs/DB06679
    Experimental

    Amediplase is a recombinant chimeric plasminogen activator, consisting of the kringle 2 domain from the A-chain of tissue plasminogen activator (t-PA) and the carboxy terminal region of pro-urokinase. [MeSH]

  7. Drug

    Iroxanadine

    go.drugbank.com/drugs/DB05444
    Experimental

    BRX-235 (iroxanadine) is a a novel small molecule synthesized by Biorex, Hungary that acts as a cardioprotective agent. It induces phosphorylation of p38 SAPK, which plays an important role in EC homeostasis. endothelial cell (EC). EC fu...

  8. Drug

    Tallimustine

    go.drugbank.com/drugs/DB15466
    Experimental

    Tallimustine, a benzoyl mustard derivative of distamycin A, is an alkylating agent that binds to the minor groove of DNA. It's association with severe myelotoxicity lead to the end of its development in favour of α-halogenoacrylamide der...

  9. Drug

    Calanolide A

    go.drugbank.com/drugs/DB04886
    Investigational

    Calanolide A is a new non-nucleoside reverse transcriptase inhibitor (NNRTI) derived from a plant found in the Malaysian rain forest. A related compound, calanolide B, also has anti-HIV activity. Both drugs are being developed by Sarawak...

  10. Drug

    SP1049C

    go.drugbank.com/drugs/DB04978
    Experimental

    SP1049C is a novel anthracycline chemotherapeutic agent containing doxorubicin and two nonionic pluronic block copolymers. It is designed to overcome drug resistance in a number of cancers. It has successfully completed Phase 1 trials. P...